| Dr Celeste Cheryll Lopez Quianzon, MD | |
|
46 Fairview Ave Ste 335, Skowhegan, ME 04976-1481 | |
| (207) 858-8216 | |
| (207) 474-8089 |
| Full Name | Dr Celeste Cheryll Lopez Quianzon |
|---|---|
| Gender | Female |
| Speciality | Endocrinology |
| Experience | 24 Years |
| Location | 46 Fairview Ave Ste 335, Skowhegan, Maine |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1881876266 | NPI | - | NPPES |
| 1881876266 | Medicaid | ME |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | MD19185 (Maine) | Secondary |
| 207R00000X | Internal Medicine | MD19185 (Maine) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Redington Fairview General Hospital | Skowhegan, ME | Hospital |
| Maine General Medical Center | Augusta, ME | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Redington-fairview General Hospital | 9133018740 | 36 |
News Archive
AEterna Zentaris Inc., ("the Company") a global biopharmaceutical company focused on endocrine therapy and oncology, today announced that Keryx Biopharmaceuticals, Inc., its partner and licensee for perifosine in the North American market, has received orphan-drug designation for this compound from the U.S. Food and Drug Administration (FDA) for the treatment of multiple myeloma.
New research suggests that plant fibers in plantains and broccoli can help prevent relapses of Crohn's disease. This disease is a long term disease of the gut that is characterized by inflammation of the lining of the digestive system, with symptoms including diarrhea and abdominal pain. Crohn's disease affects between 400,000 and 600,000 people in North America. Scientists believe that rise in processed food and decrease in fibers in diet could be a reason for rise of incidence of this disease.
Bob Massof, Ph.D., of the Wilmer Eye Institute at Johns Hopkins received the 2015 Helen Keller Prize for Vision Research on May 5...
Galectin Therapeutics, the leading developer of therapeutics that target galectin proteins to treat fibrosis and cancer, announced details today on its first-in-man Phase 1 clinical trial that will support a proposed indication of GR-MD-02 for treatment of non-alcoholic steatohepatitis (NASH, or fatty liver disease) with advanced fibrosis.
› Verified 6 days ago
| Entity Name | Redington-fairview General Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174549133 PECOS PAC ID: 9133018740 Enrollment ID: O20040312000119 |
News Archive
AEterna Zentaris Inc., ("the Company") a global biopharmaceutical company focused on endocrine therapy and oncology, today announced that Keryx Biopharmaceuticals, Inc., its partner and licensee for perifosine in the North American market, has received orphan-drug designation for this compound from the U.S. Food and Drug Administration (FDA) for the treatment of multiple myeloma.
New research suggests that plant fibers in plantains and broccoli can help prevent relapses of Crohn's disease. This disease is a long term disease of the gut that is characterized by inflammation of the lining of the digestive system, with symptoms including diarrhea and abdominal pain. Crohn's disease affects between 400,000 and 600,000 people in North America. Scientists believe that rise in processed food and decrease in fibers in diet could be a reason for rise of incidence of this disease.
Bob Massof, Ph.D., of the Wilmer Eye Institute at Johns Hopkins received the 2015 Helen Keller Prize for Vision Research on May 5...
Galectin Therapeutics, the leading developer of therapeutics that target galectin proteins to treat fibrosis and cancer, announced details today on its first-in-man Phase 1 clinical trial that will support a proposed indication of GR-MD-02 for treatment of non-alcoholic steatohepatitis (NASH, or fatty liver disease) with advanced fibrosis.
› Verified 6 days ago
| Entity Name | Eastern Maine Healthcare Systems Inland Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376579557 PECOS PAC ID: 6305817503 Enrollment ID: O20040802001656 |
News Archive
AEterna Zentaris Inc., ("the Company") a global biopharmaceutical company focused on endocrine therapy and oncology, today announced that Keryx Biopharmaceuticals, Inc., its partner and licensee for perifosine in the North American market, has received orphan-drug designation for this compound from the U.S. Food and Drug Administration (FDA) for the treatment of multiple myeloma.
New research suggests that plant fibers in plantains and broccoli can help prevent relapses of Crohn's disease. This disease is a long term disease of the gut that is characterized by inflammation of the lining of the digestive system, with symptoms including diarrhea and abdominal pain. Crohn's disease affects between 400,000 and 600,000 people in North America. Scientists believe that rise in processed food and decrease in fibers in diet could be a reason for rise of incidence of this disease.
Bob Massof, Ph.D., of the Wilmer Eye Institute at Johns Hopkins received the 2015 Helen Keller Prize for Vision Research on May 5...
Galectin Therapeutics, the leading developer of therapeutics that target galectin proteins to treat fibrosis and cancer, announced details today on its first-in-man Phase 1 clinical trial that will support a proposed indication of GR-MD-02 for treatment of non-alcoholic steatohepatitis (NASH, or fatty liver disease) with advanced fibrosis.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Celeste Cheryll Lopez Quianzon, MD Po Box 468, Skowhegan, ME 04976-0468 Ph: (207) 858-8216 | Dr Celeste Cheryll Lopez Quianzon, MD 46 Fairview Ave Ste 335, Skowhegan, ME 04976-1481 Ph: (207) 858-8216 |
News Archive
AEterna Zentaris Inc., ("the Company") a global biopharmaceutical company focused on endocrine therapy and oncology, today announced that Keryx Biopharmaceuticals, Inc., its partner and licensee for perifosine in the North American market, has received orphan-drug designation for this compound from the U.S. Food and Drug Administration (FDA) for the treatment of multiple myeloma.
New research suggests that plant fibers in plantains and broccoli can help prevent relapses of Crohn's disease. This disease is a long term disease of the gut that is characterized by inflammation of the lining of the digestive system, with symptoms including diarrhea and abdominal pain. Crohn's disease affects between 400,000 and 600,000 people in North America. Scientists believe that rise in processed food and decrease in fibers in diet could be a reason for rise of incidence of this disease.
Bob Massof, Ph.D., of the Wilmer Eye Institute at Johns Hopkins received the 2015 Helen Keller Prize for Vision Research on May 5...
Galectin Therapeutics, the leading developer of therapeutics that target galectin proteins to treat fibrosis and cancer, announced details today on its first-in-man Phase 1 clinical trial that will support a proposed indication of GR-MD-02 for treatment of non-alcoholic steatohepatitis (NASH, or fatty liver disease) with advanced fibrosis.
› Verified 6 days ago
Oto Prokop, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 46 Fairview Ave Ste 111, Skowhegan, ME 04976 Phone: 207-474-0905 Fax: 207-474-6930 | |
Donna Conkling, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 46 Fairview Ave, Suite 111, Skowhegan, ME 04976 Phone: 207-474-0905 Fax: 207-474-6930 | |
Dr. Paraschos Archontakis Barakakis, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 46 Fairview Ave, Skowhegan, ME 04976 Phone: 207-474-5121 Fax: 207-858-2415 | |
Daniel Stevenson Stadler, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 23 Cedar Ridge Dr, Skowhegan, ME 04976 Phone: 207-474-9686 | |
Dr. Rajdeep Brar, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 46 Fairview Ave, Skowhegan, ME 04976 Phone: 207-474-5121 | |
Dr. David N Abisalih, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 61 Fairview Ave, Skowhegan, ME 04976 Phone: 207-858-8121 Fax: 207-474-3648 | |
Aalia Fathima Mohamed Ghouse, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 46 Fairview Ave, Skowhegan, ME 04976 Phone: 207-474-5121 Fax: 207-858-2415 |